BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31028732)

  • 1. Pan-cancer genomic amplifications underlie a WNT hyperactivation phenotype associated with stem cell-like features leading to poor prognosis.
    Chang WH; Lai AG
    Transl Res; 2019 Jun; 208():47-62. PubMed ID: 31028732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia.
    Chang WH; Lai AG
    DNA Repair (Amst); 2019 Jun; 78():142-153. PubMed ID: 31054516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion.
    Chang WH; Lai AG
    Br J Cancer; 2019 Oct; 121(8):666-678. PubMed ID: 31523055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance.
    Chang WH; Forde D; Lai AG
    Cancer Commun (Lond); 2019 Apr; 39(1):23. PubMed ID: 31036064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.
    Chang WH; Lai AG
    J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
    Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
    Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.
    Chang WH; Forde D; Lai AG
    J Transl Med; 2019 Jan; 17(1):14. PubMed ID: 30626396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis of the developmental pathways reveals non-canonical wnt signaling as a driver of mesenchymal-type tumors.
    Xue AG; Chan M; Gujral TS
    Transl Res; 2020 Oct; 224():1-15. PubMed ID: 32522670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
    Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
    Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
    Gibbons DL; Creighton CJ
    Dev Dyn; 2018 Mar; 247(3):555-564. PubMed ID: 28073171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
    Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
    BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer.
    Zhang Q; Lou Y; Zhang J; Fu Q; Wei T; Sun X; Chen Q; Yang J; Bai X; Liang T
    Mol Cancer; 2017 Jul; 16(1):119. PubMed ID: 28705232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/β-catenin pathway.
    Ji C; Yang L; Yi W; Xiang D; Wang Y; Zhou Z; Qian F; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui Y; Bian X
    Oncogene; 2018 Jul; 37(29):3953-3966. PubMed ID: 29662192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.